Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec 15;59 Suppl 7(Suppl 7):S400-7.
doi: 10.1093/cid/ciu726.

Recruitment and retention of pregnant women into clinical research trials: an overview of challenges, facilitators, and best practices

Affiliations

Recruitment and retention of pregnant women into clinical research trials: an overview of challenges, facilitators, and best practices

Paula M Frew et al. Clin Infect Dis. .

Abstract

Pregnant women are a vulnerable group who are needed in clinical research studies to advance prevention and treatment options for this population. Yet, pregnant women remain underrepresented in clinical research. Through the lens of the socioecological model, we highlight reported barriers and facilitators to recruitment and retention of pregnant women in studies that sought their participation. We trace historical, policy-based reasons for the exclusion of pregnant women in clinical studies to present-day rationale for inclusion of this group. The findings highlight why it has been difficult to recruit and retain this population over time. A body of literature suggests that integrative sampling and recruitment methods that leverage the influence and reach of prenatal providers will overcome recruitment challenges. We argue that these strategies, in combination with building strong engagement with existing community-based organizations, will enable teams to more effectively promote and retain pregnant women in future longitudinal cohort studies.

Keywords: clinical research trials; pregnant women; recruitment; retention; vulnerable populations.

PubMed Disclaimer

References

    1. Blehar MC, Spong C, Grady C, Goldkind SF, Sahin L, Clayton JA. Enrolling pregnant women: issues in clinical research. Womens Health Issues. 2013;23:e39–45. - PMC - PubMed
    1. Group TEAS, Arrive E, Chaix ML, et al. Maternal and nenonatal tenofovir and emtricitabine to prevent vertical transmission of HIV-1: tolerance and resistance. AIDS. 2010;24:2481–8. - PubMed
    1. Wu J, Davis-Ajami ML. Antidepressant treatment persistence in low-income, insured pregnant women. J Manag Care Pharm. 2014;20:631–7. - PMC - PubMed
    1. Cleary BJ, Rice U, Eogan M, Metwally N, McAuliffe F. 2009 A/H1N1 influenza vaccination in pregnancy: uptake and pregnancy outcomes—a historical cohort study. Eur J Obstet Gynecol Reprod Biol. 2014;178:163–8. - PubMed
    1. de Vries L, van Hunsel F, Cuppers-Maarschalkerweerd B, van Puijenbroek E, van Grootheest K. Adjuvanted A/H1N1 (2009) influenza vaccination during pregnancy: description of a prospective cohort and spontaneously reported pregnancy-related adverse reactions in the Netherlands. Birth Defects Res A Clin Mol Teratol. 2014 doi:10.1002/bdra.23243. - DOI - PubMed

Publication types